Primary cutaneous actinomycosis is a rare clinical form with variable presentation. The tumoral presentation of actinomycosis as pseudocarcinomatous or sarcomatous masses is completely rare. The management of cutaneous actinomycosis needs proper antibiotic treatment and surgical resection would not be adequate alone. Herein, we report a case of primary cutaneous actinomycosis on the dorsal surface of the hand as draining and infiltrated lesions along with the scar of previous tumor excision that had not received proper antibiotics after the surgery.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120197 | PMC |
| http://dx.doi.org/10.1155/2016/5943932 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Actinomycosis of the Forearm: An Unusual Presentation of an Early Event.
Cureus
September 2024
Department of Dermatology, Coimbra Local Health Unit, Coimbra, PRT.
Article Synopsis
- Actinomycosis is a rare chronic infection primarily affecting areas like the face, lungs, or reproductive system, caused by Actinomyces bacteria.
- The disease leads to symptoms like abscesses, fistulas, and tissue damage, potentially mimicking cancerous conditions.
- A unique case of cutaneous actinomycosis on the forearm occurred without known triggers, but it was successfully treated with long-term antibiotic therapy.
Orofacial Actinomycosis Eroding Through Hard Palate: A Case Report.
WMJ
September 2024
Department of Radiology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
Article Synopsis
- Actinomycosis is a rare and serious infection caused by certain bacteria that can be found in places like our mouth and gut, with symptoms that can be confused with other illnesses.
- A 78-year-old man noticed a painless lump in his mouth, which was later diagnosed as actinomycosis after a sample of the lump was tested.
- The patient was treated with antibiotics for six months and healed completely, highlighting that this infection can be easily misdiagnosed, which delays the right treatment.
Exploring the Therapeutic Potential of High Dose Co-amoxiclav (1 gm) in Different Clinical Conditions: A Review.
Cureus
July 2024
Medical Affairs, Alkem Laboratories Ltd., Mumbai, IND.
Article Synopsis
- - Amoxicillin/clavulanate (co-amoxiclav) is a commonly used antibiotic effective against certain resistant bacteria, but there's a lack of solid data supporting current dosing guidelines.
- - A review of literature from 1992 to 2024 focused on the high-dose co-amoxiclav (875 mg/125 mg) and found it effective for various infections like pneumonia and sinusitis, often performing as well or better than other antibiotics.
- - Co-amoxiclav (875 mg/125 mg) is generally well-tolerated, primarily causing mild gastrointestinal side effects, and its optimized dosing helps improve treatment outcomes in the face of rising antibiotic resistance.
Primary Cutaneous Actinomycosis Mimicking Cutaneous Leishmaniasis.
Indian Dermatol Online J
October 2023
Department of Dermatology, Venereology and Leprosy, Grant Government Medical College and Sir JJ Group of Hospitals, Mumbai, Maharashtra, India.
Actinomycosis is a chronic suppurative bacterial infection commonly seen in the tropics, caused by gram-positive, anaerobic bacilli of the genus . There are very few reported cases of primary cutaneous actinomycosis. It can mimic mycetoma, tuberculosis, nocardiosis, and botryomycosis.
View Article and Find Full Text PDFFacial cutaneous phaeohyphomycosis in an immunocompetent individual.
Indian J Pathol Microbiol
July 2024
Department of Microbiology, Maulana Azad Medical College, New Delhi, India.
Fungal infection is a rare condition in immunocompetent individuals, and it is associated with high rates of morbidity and mortality. We report on a case of cutaneous phaeohyphomycosis in healthy 25-year-old man. Based on the clinical findings, the case was first thought to be cervico-facial actinomycosis, but Alternaria was identified on the culture after debridement.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!